CVE-2015-3965

Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.

CVSS v3 8.8 HIGH
CVSS v2.0 9.0 HIGH

8.8^/10

CVSS v3 : HIGH

Vector : AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Exploitability : 2.8 / Impact : 5.9

Attack Vector NETWORK

Attack Complexity LOW

Privileges Required LOW

User Interaction NONE

Confidentiality Impact HIGH

Integrity Impact HIGH

Availability Impact HIGH

Scope UNCHANGED

9.0^/10

CVSS v2.0 : HIGH

Vector : AV:N/AC:L/Au:S/C:C/I:C/A:C

Exploitability : 8.0 / Impact : 10.0

Access Vector NETWORK

Access Complexity LOW

Authentication SINGLE

Confidentiality Impact COMPLETE

Integrity Impact COMPLETE

Availability Impact COMPLETE

References

Link	Resource
https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01	US Government Resource Third Party Advisory

Configurations

Configuration 1 (hide)

AND

cpe:2.3:o:pfizer:symbiq_infusion_system_firmware:*:*:*:*:*:*:*:*

cpe:2.3:h:pfizer:symbiq_infusion_system:-:*:*:*:*:*:*:*

History

No history.

Information

Published : 2019-03-23 20:29

Updated : 2019-03-25 19:06

NVD link : CVE-2015-3965

Mitre link : CVE-2015-3965

CVE.ORG link : CVE-2015-3965

JSON object : View

Products Affected

pfizer

symbiq_infusion_system
symbiq_infusion_system_firmware

CWE

CWE-264

Permissions, Privileges, and Access Controls

{"id": "CVE-2015-3965", "cveTags": [], "metrics": {"cvssMetricV2": [{"type": "Primary", "source": "nvd@nist.gov", "cvssData": {"version": "2.0", "baseScore": 9.0, "accessVector": "NETWORK", "vectorString": "AV:N/AC:L/Au:S/C:C/I:C/A:C", "authentication": "SINGLE", "integrityImpact": "COMPLETE", "accessComplexity": "LOW", "availabilityImpact": "COMPLETE", "confidentialityImpact": "COMPLETE"}, "acInsufInfo": false, "impactScore": 10.0, "baseSeverity": "HIGH", "obtainAllPrivilege": false, "exploitabilityScore": 8.0, "obtainUserPrivilege": false, "obtainOtherPrivilege": false, "userInteractionRequired": false}], "cvssMetricV30": [{"type": "Primary", "source": "nvd@nist.gov", "cvssData": {"scope": "UNCHANGED", "version": "3.0", "baseScore": 8.8, "attackVector": "NETWORK", "baseSeverity": "HIGH", "vectorString": "CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H", "integrityImpact": "HIGH", "userInteraction": "NONE", "attackComplexity": "LOW", "availabilityImpact": "HIGH", "privilegesRequired": "LOW", "confidentialityImpact": "HIGH"}, "impactScore": 5.9, "exploitabilityScore": 2.8}]}, "published": "2019-03-23T20:29:00.193", "references": [{"url": "https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01", "tags": ["US Government Resource", "Third Party Advisory"], "source": "ics-cert@hq.dhs.gov"}], "vulnStatus": "Analyzed", "weaknesses": [{"type": "Primary", "source": "nvd@nist.gov", "description": [{"lang": "en", "value": "CWE-264"}]}], "descriptions": [{"lang": "en", "value": "Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger \"unanticipated operations\" by leveraging \"elevated privileges\" for an unspecified call to an incorrectly exposed function."}, {"lang": "es", "value": "Hospira Symbiq Infusion System, en versiones 3.13 y anteriores, permite que los usuarios autenticados remotos desencadenen \"operaciones no anticipadas\" aprovechando \"privilegios elevados\" para una llamada no especificada a una funci\u00f3n expuesta de manera incorrecta."}], "lastModified": "2019-03-25T19:06:55.390", "configurations": [{"nodes": [{"negate": false, "cpeMatch": [{"criteria": "cpe:2.3:o:pfizer:symbiq_infusion_system_firmware:*:*:*:*:*:*:*:*", "vulnerable": true, "matchCriteriaId": "0C60690B-14F5-401E-8204-1516A2A6CD1C", "versionEndIncluding": "3.13"}], "operator": "OR"}, {"negate": false, "cpeMatch": [{"criteria": "cpe:2.3:h:pfizer:symbiq_infusion_system:-:*:*:*:*:*:*:*", "vulnerable": false, "matchCriteriaId": "3668E376-D297-46F3-8650-CF3F62D14499"}], "operator": "OR"}], "operator": "AND"}], "sourceIdentifier": "ics-cert@hq.dhs.gov"}